148 related articles for article (PubMed ID: 21733060)
1. Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide.
Mack CM; Smith PA; Athanacio JR; Xu K; Wilson JK; Reynolds JM; Jodka CM; Lu MG; Parkes DG
Diabetes Obes Metab; 2011 Dec; 13(12):1105-13. PubMed ID: 21733060
[TBL] [Abstract][Full Text] [Related]
2. Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight.
Mack CM; Soares CJ; Wilson JK; Athanacio JR; Turek VF; Trevaskis JL; Roth JD; Smith PA; Gedulin B; Jodka CM; Roland BL; Adams SH; Lwin A; Herich J; Laugero KD; Vu C; Pittner R; Paterniti JR; Hanley M; Ghosh S; Parkes DG
Int J Obes (Lond); 2010 Feb; 34(2):385-95. PubMed ID: 19935749
[TBL] [Abstract][Full Text] [Related]
3. KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight.
Gydesen S; Andreassen KV; Hjuler ST; Christensen JM; Karsdal MA; Henriksen K
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E821-7. PubMed ID: 26908506
[TBL] [Abstract][Full Text] [Related]
4. Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).
Lutz TA; Tschudy S; Rushing PA; Scharrer E
Peptides; 2000 Feb; 21(2):233-8. PubMed ID: 10764950
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight.
Mack C; Wilson J; Athanacio J; Reynolds J; Laugero K; Guss S; Vu C; Roth J; Parkes D
Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1855-63. PubMed ID: 17855496
[TBL] [Abstract][Full Text] [Related]
6. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG
Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic amylin as a centrally acting satiating hormone.
Lutz TA
Curr Drug Targets; 2005 Mar; 6(2):181-9. PubMed ID: 15777188
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats.
Gedulin BR; Young AA
Diabetes; 1998 Jan; 47(1):93-7. PubMed ID: 9421380
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats.
Reidelberger RD; Arnelo U; Granqvist L; Permert J
Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R605-11. PubMed ID: 11171636
[TBL] [Abstract][Full Text] [Related]
10. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin.
Lutz TA; Del Prete E; Scharrer E
Peptides; 1995; 16(3):457-62. PubMed ID: 7651899
[TBL] [Abstract][Full Text] [Related]
11. Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids.
Trevaskis JL; Mack CM; Sun C; Soares CJ; D'Souza LJ; Levy OE; Lewis DY; Jodka CM; Tatarkiewicz K; Gedulin B; Gupta S; Wittmer C; Hanley M; Forood B; Parkes DG; Ghosh SS
PLoS One; 2013; 8(10):e78154. PubMed ID: 24167604
[TBL] [Abstract][Full Text] [Related]
12. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.
Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW
Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519
[TBL] [Abstract][Full Text] [Related]
13. The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy.
Larsen AT; Sonne N; Andreassen KV; Gehring K; Karsdal MA; Henriksen K
J Pharmacol Exp Ther; 2019 Jul; 370(1):35-43. PubMed ID: 31028106
[TBL] [Abstract][Full Text] [Related]
14. Rodent models of leptin receptor deficiency are less sensitive to amylin.
Duffy S; Lutz TA; Boyle CN
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R856-R865. PubMed ID: 30133304
[TBL] [Abstract][Full Text] [Related]
15. Control of food intake and energy expenditure by amylin-therapeutic implications.
Lutz TA
Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S24-7. PubMed ID: 19363503
[TBL] [Abstract][Full Text] [Related]
16. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
Züger D; Forster K; Lutz TA; Riediger T
Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370
[TBL] [Abstract][Full Text] [Related]
17. Biological activity of AC3174, a peptide analog of exendin-4.
Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
[TBL] [Abstract][Full Text] [Related]
18. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.
Mollet A; Gilg S; Riediger T; Lutz TA
Physiol Behav; 2004 Mar; 81(1):149-55. PubMed ID: 15059694
[TBL] [Abstract][Full Text] [Related]
19. Synergy between amylin and cholecystokinin for inhibition of food intake in mice.
Bhavsar S; Watkins J; Young A
Physiol Behav; 1998 Jun; 64(4):557-61. PubMed ID: 9761232
[TBL] [Abstract][Full Text] [Related]
20. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD
Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
